お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
524433

先端巨大症(AC) - 疫学的予測

Acromegaly - Epidemiology Forecast to 2028

出版日: 受注後作成 | 発行: DelveInsight Business Research LLP | ページ情報: 英文 50 Pages | 納期: 約10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.25円
先端巨大症(AC) - 疫学的予測
出版日: 受注後作成
発行: DelveInsight Business Research LLP
ページ情報: 英文 50 Pages
納期: 約10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

主要7カ国(米国、英国、ドイツ、フランス、イタリア、スペイン、日本)における先端巨大症(AC)の総有病数は2016年に6万610人と見積もられています。

当レポートでは、先端巨大症(AC)について調査し、疾病の概要、患者背景、主要7カ国における先端巨大症(AC)の有病数・診断数・治療可能な症例数の予測(今後10年間分)、市場の成長機会などを包括的にまとめています。

目次

第1章 重要な洞察

第2章 疾患概要:先端巨大症(AC)

  • イントロダクション
  • 兆候と症状
  • 下垂体腺腫の分類
  • 先端巨大症の臨床症状
  • 病因
  • 病態生理
  • 先端巨大症の遺伝的要因
  • 病因
  • 診断
    • 診断ガイドライン
    • 内分泌学会診療ガイドライン作成委員(英国)
    • 米国臨床内分泌学会(米国)

第3章 疫学と患者人口

第4章 主な所見

第5章 主要7カ国の疫学

  • 主要7カ国における先端巨大症の総有病数
  • 主要7カ国における先端巨大症の有病数:原因別

第6章 米国の疫学

  • 先端巨大症(AC)の有病数
  • 先端巨大症(AC)の有病数:原因別
  • 先端巨大症(AC)の診断数
  • 先端巨大症(AC)の診断数:腺腫別
  • 先端巨大症(AC)の治療可能な症例数

第7章 欧州5カ国の疫学

  • 英国
    • 先端巨大症(AC)の有病数
    • 先端巨大症(AC)の有病数:原因別
    • 先端巨大症(AC)の診断数
    • 先端巨大症(AC)の診断数:腺腫別
    • 先端巨大症(AC)の治療可能な症例数
  • ドイツ
    • 先端巨大症(AC)の有病数
    • 先端巨大症(AC)の有病数:原因別
    • 先端巨大症(AC)の診断数
    • 先端巨大症(AC)の診断数:腺腫別
    • 先端巨大症(AC)の治療可能な症例数
  • フランス
    • 先端巨大症(AC)の有病数
    • 先端巨大症(AC)の有病数:原因別
    • 先端巨大症(AC)の診断数
    • 先端巨大症(AC)の診断数:腺腫別
    • 先端巨大症(AC)の治療可能な症例数
  • イタリア
    • 先端巨大症(AC)の有病数
    • 先端巨大症(AC)の有病数:原因別
    • 先端巨大症(AC)の診断数
    • 先端巨大症(AC)の診断数:腺腫別
    • 先端巨大症(AC)の治療可能な症例数
  • スペイン
    • 先端巨大症(AC)の有病数
    • 先端巨大症(AC)の有病数:原因別
    • 先端巨大症(AC)の診断数
    • 先端巨大症(AC)の診断数:腺腫別
    • 先端巨大症(AC)の治療可能な症例数

第8章 日本の疫学

  • 先端巨大症(AC)の有病数
  • 先端巨大症(AC)の有病数:原因別
  • 先端巨大症(AC)の診断数
  • 先端巨大症(AC)の診断数:腺腫別
  • 先端巨大症(AC)の治療可能な症例数

第9章 アンメットニーズ

第10章 付録

  • 調査方法

第11章 DelveInsightのサービス内容

第12章 免責事項

第13章 DelveInsightについて

図表

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Acromegaly in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Acromegaly in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Acromegaly in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Acromegaly in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Acromegaly in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Acromegaly in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Acromegaly in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Acromegaly in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Acromegaly in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Acromegaly in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Acromegaly in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Acromegaly in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Acromegaly in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Acromegaly in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Acromegaly in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Acromegaly in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Acromegaly in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Acromegaly in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Acromegaly in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Acromegaly in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Acromegaly in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Acromegaly in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Acromegaly in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Acromegaly in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Acromegaly in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Acromegaly in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Acromegaly in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Acromegaly in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Acromegaly in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Acromegaly in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Acromegaly in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Acromegaly in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Acromegaly in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Acromegaly in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Acromegaly in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Acromegaly in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Acromegaly in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Acromegaly in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Acromegaly in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Acromegaly in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Acromegaly in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Acromegaly in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Acromegaly in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Acromegaly in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Acromegaly in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Acromegaly in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Acromegaly in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Acromegaly in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Acromegaly in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Acromegaly in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Acromegaly in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Acromegaly in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Acromegaly in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Acromegaly in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Acromegaly in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Acromegaly in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Acromegaly in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Acromegaly in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Acromegaly in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Acromegaly in Japan (2016-2028)
目次
Product Code: DIEI0017

DelveInsight's "Acromegaly - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Acromegaly epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Acromegaly Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Acromegaly in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Acromegaly outlook. It also includes the explanation of changing trends of epidemiology outlining the Acromegaly scenario.

Acromegaly Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Acromegaly thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Acromegaly explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Acromegaly Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Acromegaly

Key assessments

  • Patient Segmentation in Acromegaly
  • Acromegaly Risk & Burden
  • Factors driving growth in a specific Acromegaly patient population

Table of Contents

1. Report Introduction

2. Acromegaly Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Acromegaly in 2016
  • 2.2. Patient Share Distribution of Acromegaly in 2028

3. Disease Background and Overview: Acromegaly

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Acromegaly in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Acromegaly in 7MM - By Countries

5. Epidemiology of Acromegaly by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Acromegaly
    • 5.1.3. Sub-Type Specific cases of the Acromegaly *
    • 5.1.4. Sex- Specific Cases of the Acromegaly *
    • 5.1.5. Diagnosed Cases of the Acromegaly
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Acromegaly
    • 5.4.3. Sub-Type Specific cases of the Acromegaly *
    • 5.4.4. Sex- Specific Cases of the Acromegaly *
    • 5.4.5. Diagnosed Cases of the Acromegaly
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Acromegaly
    • 5.5.3. Sub-Type Specific cases of the Acromegaly *
    • 5.5.4. Sex- Specific Cases of the Acromegaly *
    • 5.5.5. Diagnosed Cases of the Acromegaly
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Acromegaly
    • 5.6.3. Sub-Type Specific cases of the Acromegaly *
    • 5.6.4. Sex- Specific Cases of the Acromegaly *
    • 5.6.5. Diagnosed Cases of the Acromegaly
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Acromegaly
    • 5.7.3. Sub-Type Specific cases of the Acromegaly *
    • 5.7.4. Sex- Specific Cases of the Acromegaly *
    • 5.7.5. Diagnosed Cases of the Acromegaly
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Acromegaly
    • 5.8.3. Sub-Type Specific cases of the Acromegaly *
    • 5.8.4. Sex- Specific Cases of the Acromegaly *
    • 5.8.5. Diagnosed Cases of the Acromegaly
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Acromegaly
    • 5.9.3. Sub-Type Specific cases of the Acromegaly *
    • 5.9.4. Sex- Specific Cases of the Acromegaly *
    • 5.9.5. Diagnosed Cases of the Acromegaly

6. Unmet Needs of the Acromegaly

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.